AHRO Stock News 0.3580 05/06/2014 13:17:55 Atheronova Inc (A

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Atheronova Inc (AHRO) 0.3580 $AHRO

AtheroNova 1-for-10 Reverse Stock Split Effective
GlobeNewswire - Tue Apr 22, 8:14AM CDT
AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that the reverse stock split approved by the Company's stockholders at last week's annual stockholder's meeting became effective as of the opening of trading on Tuesday, April 22, 2014.

AtheroNova hires Dr. Randolph M. Johnson as COO
M2 - Wed Apr 09, 4:19AM CDT
Biotech company AtheroNova (Other OTC:AHRO) stated on Tuesday that Dr. Randolph M. Johnson, Ph.D. has been elected as its chief operating officer.

AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer
GlobeNewswire - Tue Apr 08, 8:39AM CDT
AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Randolph M. Johnson, Ph.D. has joined the Company as Chief Operating Officer.

AtheroNova Announces 2013 Financial Results
GlobeNewswire - Thu Mar 06, 8:23AM CST
AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced its financial results for the year-ended December 31, 2013 and is providing a corporate update on operations and progress on lead candidate AHRO-001.

AtheroNova Announces Preliminary Positive Phase 1 Clinical Data From Lead Drug AHRO-001, a Potential Treatment for Atherosclerosis
GlobeNewswire - Thu Feb 27, 8:52AM CST
AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced the release of preliminary findings from its Phase 1 clinical trial with its lead compound, AHRO-001. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

Liberty Software and VUCA Health Partner to Enhance Patient Safety and Provide Pharmacies with an Innovative Patient Engagement Tool
PR Newswire - Fri Jan 17, 8:08AM CST
VUCA Health, which has created the largest and most robust medication video library in the world to address health literacy, announced today that Liberty Software, a leading pharmacy management solution focused on innovation and customer service, will offer the MedsOnCue solution to its base of pharmacies.

Global Microspheres Market Report 2013 - Global Trends & Forecasts to 2018
PR Newswire - Wed Jan 08, 1:13PM CST
Research and Markets (http://www.researchandmarkets.com/research/6s2fj8/microspheres) has announced the addition of the "Global Microspheres Market Report 2013 - Global Trends & Forecasts to 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

10-K: ESTERLINE TECHNOLOGIES CORP
Edgar Online - Fri Dec 20, 3:08PM CST
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

Farmers Files Lawsuit Seeking More Than $3 Million Against Radiological Corporations And Their Owners For Allegedly Billing For Services Never Rendered
PR Newswire - Thu Dec 19, 10:32AM CST
Farmers Insurance Exchange®, 21st Century Insurance Company®, Coast National Insurance Company®, Mid-Century Insurance Company®, and Truck Insurance Exchange® ("Farmers" have filed a lawsuit in the Superior Court of California against two radiological corporations and their owners alleging they prepared and submitted false and misleading documentation to receive payment for services never provided. The detailed civil complaint seeks restitution and additional remedies for alleged violations of California's Unfair Business Practices (Business and Professions Code 17200) as well as the Insurance Frauds Prevention Act (Insurance Code 1871.7), and an order directing Defendants to cease and desist from engaging in alleged improper billing practices.

AtheroNova Inc enrols 54 subjects in Russia under Phase 1 clinical trial of AHRO-001 for potential treatment of atherosclerosis
M2 - Fri Dec 06, 9:55AM CST
Biotech company AtheroNova Inc (Other OTC:AHRO) said on Thursday that it has completed the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001.

AtheroNova Completes Enrollment in Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis
PR Newswire - Thu Dec 05, 6:00AM CST
AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

AtheroNova to Present at the 2013 Aegis Healthcare Conference in Las Vegas
PR Newswire - Thu Sep 19, 6:00AM CDT
AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Chairman and CEO, Thomas W. Gardner, will present a corporate overview at the 2013 Aegis Capital Healthcare Conference. The presentation will take place at 9:00am PT on Saturday, September 28 at The Encore at Wynn in Las Vegas, NV.

AtheroNova Inc. Presenting at 15th Annual Rodman & Renshaw Investment Conference
Marketwire - Wed Sep 04, 12:08PM CDT
AtheroNova Inc. (OTCQB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. AtheroNova will be presenting on Monday, September 9 at 12:05pm EDT. The conference is being held September 8-10, 2013, at the Millennium Broadway Hotel in New York City.

Medical Marijuana, Biotech and Precious Metals Micro-Caps Under the Radar
Marketwire - Tue Aug 27, 8:52AM CDT
Virtual Sourcing, Inc. (PINKSHEETS: PGCX) pursues business opportunities in fiberglass recycling and marketing manufactured products made from recycled fiberglass fibers, other fibers and virgin materials. PGCX has announced ambitious growth plans throughout the month of August. Read about them all at the following link: http://bit.ly/REPORTPGCX

OTC Daily Alert Stock Watch - AtheroNova Inc (OTCBB: AHRO )
WorldStockWire - Sat Aug 10, 8:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

AtheroNova, Amgen and More Leveraging Russian Initiatives to Grow Biotech Sector
ACCESSWIRE - Thu Jul 18, 9:00AM CDT
"Life is short, and the process is long." That's what Cleveland BioLabs (NASDAQ: CBLI) President Dr. Michael Fonstein told Forbes last year while discussing the U.S. Food and Drug Administration's regulatory process. Cleveland BioLabs shifted the development of several of their drugs from the U.S. to Russia, the birthplace of the company and a land where regulations are more flexible, in order to expedite the process towards commercialization.

AtheroNova's AHRO-001 Targets Much More than Cholesterol, Shows New UCLA Study
ACCESSWIRE - Tue Jul 02, 9:52AM CDT
Metabolic Syndrome ("MS" affects approximately a quarter of the U.S. population, according to a 2002 National Health and Nutrition Examination Survey. Characterized by raised triglycerides, reduced HDL cholesterol, high BMI/waistline, raised blood pressure, and raised fasting plasma glucose, the syndrome significantly increases the risk of heart disease and a host of other health problems, including stroke, diabetes and some common forms of cancer.

AtheroNova Announces Publication of Positive Pre-Clinical Results with AHRO-001 in the FASEB Journal
PR Newswire - Thu Jun 27, 7:00AM CDT
AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced publication of the preclinical study that supported the clinical development of the Company's investigational AHRO-001 drug. The study, which was conducted by scientists at the David Geffen School of Medicine, University of California Los Angeles, was published in the June 10, 2013 online issue of the FASEB Journal in advance of the print issue.

AtheroNova Inc initiates Phase 1 clinical trial of AHRO-001 for the potential treatment of atherosclerosis
M2 - Wed Jun 26, 6:45AM CDT
Biotech company AtheroNova Inc (OTC Markets:AHRO) reported on Tuesday the launch of its milestone Phase 1 clinical trial with its lead compound, AHRO-001, for the potential treatment of atherosclerosis.

Combining Therapies to Amplify the Effects of Statins
ACCESSWIRE - Wed Jun 12, 8:51AM CDT
Statins, drugs that improve blood cholesterol levels by inhibiting the liver enzyme HMG Co-A reductase, are some of the most widely prescribed drugs in the United States. Increasing diabetes and obesity rates are real problem, resulting in doctors working the script pad like never before in the last decade. Three of the 20 best-selling drugs of all-time are statins used in the treatment of dyslipidemia, a condition where a person has an abnormally high amount of lipids (cholesterol or fat) in their blood.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Waterfall Backs $48M Loan for Disney-area Hotel Upgrade

Updated Category News Views 175

A $48 Million Shot in the Arm for Portofino Inn Old-school Anaheim just got a real estate shake-up. Waterfall Asset Management's decision to lend a hefty $48 million to Dynamic City Capital (DCC) is more than just a financial move—it's a bet on tourism's bedrock, Disneyland. They're sinking this cash into the Portofino Inn & Suites, located a stone's throw from the...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 33

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 81

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
Monotype Unveils Font Tool for Adobe: A Game-Changer?

Updated Category News Views 50

Monotype Connect: Fonts Meet Convenience Imagine fighting through a blizzard with a flashlight. That's how designers juggle fonts without a central tool. Well, Monotype's got them covered with the new Connect panel for Adobe apps—a beacon of efficiency spotted at Adobe MAX 2026 in Miami Beach. Efficiency and Brand Unity: Partners in Design Now, here’s why this isn’t...

Continue Reading
Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 79

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
Qfin Holdings Faces Securities Fraud Lawsuit Scrutiny

Updated Category News Views 23

Qfin Holdings Stumbles Under Legal Microscope Picture this—you're riding the stock market wave and then, out of nowhere, your investment gets hit by a sudden drop, leaving you scrambling for answers. That's the scenario investors in Qfin Holdings, Inc. (NASDAQ: QFIN) find themselves in after the company’s stock plunged by nearly 19%. Now, they're not just left...

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 39

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
Ericsson Completes Major Buyback in November Burst

Updated Category News Views 65

Ericsson's Aggressive Share Repurchase Strategy Ericsson's share buyback spree might not be the first rodeo for seasoned investors out there, but their recent grab between November 9th and 13th surely made a few heads turn. The telecom giant snatched up a neat pile of 500,000 of its own Class B shares, maintaining the steady tick of their ambitious buyback program. It's...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 36

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 95

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading

Top 5 Most Recently Viewed Articles

Birkenstock Holding Q1 Earnings Highlights and Insights

Updated Category News Views 174

Birkenstock Holding Q1 Earnings Overview Birkenstock Holding (NYSE: BIRK) recently shared insights from its first quarter earnings report, showcasing the company’s financial performance and strategic advancements. This update reveals not only earnings results but also highlights on how the company is faring in a competitive market. Earnings Results The company's...

Continue Reading
Kinepolis Group Announces Upcoming Dividend Payment Details

Updated Category News Views 228

Kinepolis Group Dividend Announcement The Kinepolis Group NV is pleased to inform its shareholders of an upcoming dividend payout, a noteworthy event for investors looking to maximize their returns. Dividend Payment Details The company has officially announced a gross dividend of €0.55 per share. After the deduction of the standard 30% withholding tax, shareholders will...

Continue Reading
Celebrating Success: Medical Solutions Recognized in Regionals

Updated Category News Views 144

Celebrating Growth and Achievement for Medical Solutions Recognized for three consecutive years as a leader in healthcare workforce solutions Medical Solutions, a prominent name in healthcare workforce solutions, has been honored once again for its exceptional growth trajectory, being listed among the Midwest's fastest-growing companies. This prestigious recognition marks...

Continue Reading
Unlocking the Future: SEALSQ's MS6003 Secure Element Launch

Updated Category News Views 208

Revolutionizing Secure Authentication with MS6003 SEALSQ Corp (NASDAQ: LAES), a leader in semiconductor innovation, has recently announced a significant addition to its product portfolio: the MS6003 secure element chip. This state-of-the-art chip is equipped with a preloaded FIDO2 application, marking a pivotal step towards enhancing passwordless authentication in an era...

Continue Reading
Navigating Income with High-Dividend Utility Stocks Today

Updated Category News Views 114

Staying Afloat with Utility Stocks In challenging market conditions, many investors search for stability. This leads them to utility stocks, particularly those offering attractive dividend yields. Utilities often provide steady cash flows and dividends, making them appealing for income-seeking investors. Dividend Opportunities in Utilities Sector As the market shifts,...

Continue Reading